CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded JCR Q1 Özgün Makale Scopus
COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
European Journal of Pediatrics 2022 Cilt 181
Scopus Eşleşmesi Bulundu
39
Atıf
181
Cilt
2031-2043
Sayfa
🔓
Açık Erişim
Özet
Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9–12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells × μL, p = 0.028; platelet count 166 vs. 216 cells × 103/μL, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 µg/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217–0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244–5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298–0.559). Conclusion: Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD.What is Known:• In some cases of MIS-C, the clinical symptoms overlap with Kawasaki disease.• Compared to Kawasaki disease, lymphopenia was an independent predictor of MIS-C.What is New:• Half of the patients had clinical features that overlapped with Kawasaki disease.• In patients whose clinical features overlapped with KD, procalcitonin levels were almost 15 times higher than normal.• Lethargy increased the risk of overlap with KD by 2.6-fold in MIS-C patients.• Transient bradycardia was noted in approximately 10% of our patients after initiation of treatment.
Web of Science Eşleşmesi Bulundu
39
WoS Atıf
181
Cilt
Article
Belge Türü
Kaynak: EUROPEAN JOURNAL OF PEDIATRICS · s. 2031-2043
Anahtar Kelimeler (WoS)

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 39.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.

Anahtar Kelimeler

WoS | Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.

Makale Bilgileri

Dergi European Journal of Pediatrics
ISSN 0340-6199 / eISSN:1432-1076
Yıl 2022 / 2. ay
Cilt / Sayı 181
Sayfalar 2031 – 2043
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
JCR Quartile Q1
Teşvik Puanı 0,29 · YÖKSİS Akademik Teşvik
Yayın Dili İngilizce
Kapsam Uluslararası
Toplam Yazar 63 kişi
Erişim Türü Elektronik
Alan Sağlık Bilimleri Temel Alanı Çocuk Sağlığı ve Hastalıkları

YÖKSİS Yazar Kaydı

Yazar Adı YILMAZ ÇİFTDOĞAN DİLEK, EKEMEN KELEŞ YILDIZ, ÇETİN BENHUR ŞİRVAN
YÖKSİS ID 6176130

Metrikler

Scopus Atıf 39
Havuz Atıfları 0
JCR Quartile Q1
Teşvik Puanı 0,29
Yazar Sayısı 63